Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.

Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitor.

Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines.

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.

Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis Factor Pathway.

Mechanisms of cisplatin cytotoxicity in human ovarian carcinoma cell lines.

Tumor necrosis factor and chemotherapeutic agents. Potentiation of cytotoxicity with interferon gamma.

[Therapy of ascites with tumor necrosis factor in ovarian cancer].

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines.

Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.

Mitogenic stimulation of human tumor-infiltrating lymphocytes by secreted factor(s) from human tumor cell lines.

Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines.

Effects of tumor necrosis factor, alone or in combination with topoisomerase-II-targeted drugs, on human lung cancer cell lines.

Synergistic activity of suramin with tumor necrosis factor alpha and doxorubicin on human prostate cancer cell lines.

Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.

Growth inhibition of human colorectal carcinoma cell lines by tumor necrosis factor-alpha correlates with reduced activity of pp60c-src.

Lymphoblastogenesis inhibitory factor produced by human lung cancer cell lines.

In vitro cytotoxicity of human recombinant tumor necrosis factor alpha in association with radiotherapy in a human ovarian carcinoma cell line.

Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.

NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines.

Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.

Anticancer Activity of Pterostilbene in Human Ovarian Cancer Cell Lines.

Suggest Documents

Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitor.

Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines.

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.

Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis Factor Pathway.

Mechanisms of cisplatin cytotoxicity in human ovarian carcinoma cell lines.

Tumor necrosis factor and chemotherapeutic agents. Potentiation of cytotoxicity with interferon gamma.

[Therapy of ascites with tumor necrosis factor in ovarian cancer].

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines.

Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.

Mitogenic stimulation of human tumor-infiltrating lymphocytes by secreted factor(s) from human tumor cell lines.

Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines.

Effects of tumor necrosis factor, alone or in combination with topoisomerase-II-targeted drugs, on human lung cancer cell lines.

Synergistic activity of suramin with tumor necrosis factor alpha and doxorubicin on human prostate cancer cell lines.

Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.

Growth inhibition of human colorectal carcinoma cell lines by tumor necrosis factor-alpha correlates with reduced activity of pp60c-src.

Lymphoblastogenesis inhibitory factor produced by human lung cancer cell lines.

In vitro cytotoxicity of human recombinant tumor necrosis factor alpha in association with radiotherapy in a human ovarian carcinoma cell line.

Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.

NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines.

Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.

Anticancer Activity of Pterostilbene in Human Ovarian Cancer Cell Lines.

Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.

Recommend Documents

Follow Us